Insights

Podcasts

Treatment Efficacy for Parkinson Disease-Related Anxiety

06/29/2021

Julie Gould

Maria Asimopoulos

Ruth Schneider, MD, assistant professor and director, Huntington’s Disease Society of America Center of Excellence, University of Rochester, discusses her recent research that examined patient outcomes and responses to buspirone in the...

Ruth Schneider, MD, assistant...

06/29/2021

Annals of Long-Term Care

Videos

Beneficial Treatments for OFF Episodes Among Patients With PD

02/18/2021

Maria C Ospina, MD, movement disorder neurologist, discusses how physicians can ensure they receive all of the information needed to unlock patterns of Parkinson disease among their patients, and breaks down treatment options for OFF episodes...

Maria C Ospina, MD, movement...

02/18/2021

Annals of Long-Term Care

Videos

Parkinson Disease: Therapeutic Interventions and How Care Has Changed Since COVID First Struck

11/17/2020

Luca Marsili MD, PhD, Gardner Family Center for Parkinson's Disease and Movement Disorders, discusses how the care of Parkinson disease (PD) has changed since the start of the pandemic and explains why guidelines for choosing the appropriate...

Luca Marsili MD, PhD, Gardner...

11/17/2020

Annals of Long-Term Care

Interview

A Potential Blood Test for Parkinson Disease

05/14/2019

Despite Parkinson disease diagnosis challenges, new research shines light on a potential noninvasive diagnostic test. Professor of neurology at the Brain Research Institute Gal Bitan, PhD, discusses his recent study findings.

Despite Parkinson disease...

05/14/2019

Annals of Long-Term Care

Interview

Determining Appropriate Time to Initiate PD Treatment

03/12/2019

Rob di Bie, MD, PhD, neurologist and professor of Movement Disorders at the University of Amsterdam’s Faculty of Medicine, discusses the long-term effects of a specific PD medication and the impact of starting the drug early.

Rob di Bie, MD, PhD, neurologist...

03/12/2019

Annals of Long-Term Care

Podcasts

Is it Safe to Treat PD With a Drug Approved for Psuedobulbar Affect?

02/21/2019

Michael Fralick, MD, FRCPC, Brigham and Women’s Hospital, discusses his recent study that examined a medication approved for psuedobulbar affect, which he found was regularly being prescribed to patients with PD and dementia. He explains why...

Michael Fralick, MD, FRCPC,...

02/21/2019

Annals of Long-Term Care

Annals of Long-Term Care Newsletter

Insights

Specialties

Events

Year Round Education

HMP Global Products